Related Experiment Video

Updated: Aug 16, 2026

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts
10:04

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts

Published on: January 8, 2017

Ploidy status rarely changes in myeloma patients at disease progression

W J Chng1, J M Winkler, P R Greipp

  • 1Mayo Clinic Scottsdale, Comprehensive Cancer Center, Division of Haematology-Oncology, Johnson Research Building, Scottsdale, AZ 85259, USA.

Leukemia Research
|August 23, 2005
PubMed

Insights

Multiple myeloma ploidy status, hyperdiploid or non-hyperdiploid, generally remains stable from diagnosis to progression. Most patients maintain their initial genetic subtype throughout the disease course.

Area of Science:

  • Hematology
  • Oncology
  • Cancer Genetics

Background:

  • Multiple myeloma (MM) is characterized by distinct genetic subtypes, including hyperdiploid and non-hyperdiploid categories.
  • These genetic differences suggest potentially divergent biological behaviors and clinical outcomes.

Purpose of the Study:

  • To investigate the stability of ploidy status (hyperdiploid vs. non-hyperdiploid) in multiple myeloma patients over time.
  • To determine if ploidy category changes from initial diagnosis to disease progression.

Main Methods:

  • Analysis of 43 multiple myeloma patients using flow cytometry DNA index and FISH-based index.
  • Comparison of ploidy status at diagnosis versus at progression.

Main Results:

  • Only 12% (5 out of 43) of patients altered their ploidy status at progression.
  • In most cases, changes were minimal and potentially attributable to technical artifacts.
  • Patients retaining their ploidy subtype showed minimal DNA index change (3.75+/-4.87%).

Conclusions:

  • Ploidy category in multiple myeloma appears to be a stable characteristic throughout disease evolution.
  • The initial genetic events defining hyperdiploid and non-hyperdiploid subtypes persist during disease progression.
  • This stability supports the concept of distinct biological entities for hyperdiploid and non-hyperdiploid multiple myeloma.

More Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

Related Concept Videos

Nondisjunction01:29

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
Polytene Chromosomes02:04

Polytene Chromosomes

Polytene chromosomes are giant interphase chromosomes with several DNA strands placed side by side. They were discovered in the year 1881 by Balbiani in salivary glands, intestine, muscles, malpighian tubules, and hypoderm of larvae Chironomus plumosus. Hence, these are also called "Salivary gland chromosomes." These are found in insects of the order Diptera and Collembola; in certain organs of mammals; and synergids, antipodes of flowering plants. Polytene chromosomes are also regularly...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...